Basal & Squamous Cell Skin Cancers in Adults

We established one of the first treatment programs in the New York City area for basal and squamous cell cancers, also called nonmelanoma skin cancers. Our dermatologists’ expertise in identifying and removing precancerous growths helps prevent many of these skin cancers from developing. When cancer is diagnosed, our medical oncologists, surgical oncologists, and radiation oncologists work together to provide the most effective treatment. Our reconstructive surgeons and rehabilitation doctors may also play an important role in your care.

Clinical Trials and Research Studies

Phase 5

Phase I/II study of dabrafenib trametinib and navitoclax in BRAF mutant melanoma (Phase I and II) and other solid tumors (Phase I only).

Learn More

Phase 2

A Phase II Study of Talimogene laherparepvec Followed by Talimogene laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas Cutaneous Squamous Cell Carcinoma Merkel Cell Carcinoma and Other Rare Skin Tumors

Learn More

Phase 2

A Randomized Controlled Open-Label Phase 2 Study of Cemiplimab as a Single Agent and in Combination with RP1 in Patients with Advanced Cutaneous Squamous Cell Carcinoma

Learn More

Phase 1

A PHASE 1 STUDY OF PRE-OPERATIVE CEMIPLIMAB (REGN2810) ADMINISTERED INTRALESIONALLY FOR PATIENTS WITH RECURRENT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)

Learn More